Combination Therapy with Rituximab and Temozolomide for Recurrent and Refractory Primary Central Nervous System Lymphoma

High-dose methotrexate-based chemotherapy has extended survival in patients with primary central nervous system lymphoma (PCNSL). However, although salvage treatment is necessary in recurrent and refractory PCNSL, this has not been standardized. We herein describe the efficacy of a combination of ri...

Full description

Saved in:
Bibliographic Details
Main Authors: Murakami, Mineko, Fujimaki, Takamitsu, Asano, Shuichiro, Nakaguchi, Hiroshi, Yamada, Shoko M., Hoya, Katsumi, Yamazaki, Kazuto, Ishida, Yasuo, Matsuno, Akira
Format: Artigo
Language:Inglês
Published: Yonsei University College of Medicine 2011
Subjects:
Case Report
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3220260/
https://ncbi.nlm.nih.gov/pubmed/22028172
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2011.52.6.1031
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items